​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $73.77, with a high of $85.43 and a low of $60.30. This represents a -0.34% decline from the last price of $74.02.

$20 $34 $48 $62 $76 $90 High: $85.43 Avg: $73.77 Low: $60.3 Last Closed Price: $74.02

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

PRAX Forecast vs Benchmarks

TypeNameUpside
StockPraxis Precision Medicines-0.34%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--9
Avg Price Target--$71.59
Last Closing Price$74.02$74.02$74.02
Upside/Downside---3.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25361--10
Dec, 24361--10
Nov, 24461--11
Oct, 24461--11
Sep, 24461--11
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 04, 2024Douglas TsaoH.C. Wainwright$60.30$29.25106.15%-18.54%
Sep 04, 2024Ami FadiaNeedham$75.90$29.25159.49%2.54%
Sep 03, 2024Francois BriseboisOppenheimer$71.85$27.83158.17%-2.93%
Sep 03, 2024Joon LeeTruist Financial$75.38$27.08178.36%1.84%
Aug 14, 2024Ami FadiaNeedham$72.90$25.73183.33%-1.51%
Aug 14, 2024Yatin SunejaGuggenheim$85.43$26.25225.45%15.41%
Aug 05, 2024Francois BriseboisOppenheimer$67.35$26.93150.09%-9.01%
May 28, 2024Kambiz YazdiJefferies$70.88$22.13220.29%-4.24%
Mar 26, 2024Kambiz YazdiJefferies$64.35$31.28105.72%-13.06%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024OppenheimerOutperformOutperformhold
Sep 24, 2024Cowen & Co.BuyBuyhold
Sep 04, 2024Piper SandlerUnderperformUnderperformhold
Sep 04, 2024NeedhamBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Sep 03, 2024OppenheimerOutperformOutperformhold
Sep 03, 2024Cowen & Co.BuyBuyhold
Aug 21, 2024Piper SandlerOverweightOverweighthold
Aug 14, 2024GuggenheimBuyBuyhold
Aug 14, 2024WedbushNeutralNeutralhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.02-----
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Low Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Surprise %-99.90%-----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M-----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Low Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Surprise %28.79%-----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M-----
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Low Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Surprise %------

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 7 Wall Street analysts, averages $73.77 over the next 12 months. The price target range spans from $60.3 at the low end to $85.43 at the high end, suggesting a potential -0.34% change from the previous close price of $74.02.

How does Praxis Precision Medicines stock forecast compare to the average forecast of its sector, industry, and investment themes?

Praxis Precision Medicines stock forecast shows a -0.34% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • January 2025: 30.00% Strong Buy, 60.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 30.00% Strong Buy, 60.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 36.36% Strong Buy, 54.55% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December is -10.2 for 2024, a 50900.00% increase from the reported $-0.02 in 2023. The prediction for 2025 is $-11.47, $-11.46 for 2026, $-9.52 for 2027, and $-2.37 for 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December is $1.47M for 2024, a -40.09% decrease from the reported $2.45M in 2023. The forecast for 2025 is $967.3K, $31.98M for 2026, $101.46M for 2027, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

For its fiscal year ending in December, Praxis Precision Medicines's average annual net income forecast is $-67.223M for 2024, reflecting a -45.47% decrease from the reported $-123M in 2023. The projection for 2025 is $-75.239M, $-85.528M for 2026, $-66.138M for 2027, and $-15.629M for 2028.